Reaction Details |
| Report a problem with these data |
Target | Amine oxidase [flavin-containing] B |
---|
Ligand | BDBM15581 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_1557703 (CHEMBL3772921) |
---|
IC50 | 61350±n/a nM |
---|
Citation | Distinto, S; Meleddu, R; Yanez, M; Cirilli, R; Bianco, G; Sanna, ML; Arridu, A; Cossu, P; Cottiglia, F; Faggi, C; Ortuso, F; Alcaro, S; Maccioni, E Drug design, synthesis, in vitro and in silico evaluation of selective monoaminoxidase B inhibitors based on 3-acetyl-2-dichlorophenyl-5-aryl-2,3-dihydro-1,3,4-oxadiazole chemical scaffold. Eur J Med Chem108:542-52 (2016) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Amine oxidase [flavin-containing] B |
---|
Name: | Amine oxidase [flavin-containing] B |
Synonyms: | AOFB_HUMAN | MAO-B | MAOB | Monoamine oxidase type B | Monoamine oxidase type B (MAO B) | Monoamine oxidase type B (MAO B) | Monoamine oxidase type B (MAOB) |
Type: | Protein |
Mol. Mass.: | 58768.76 |
Organism: | Homo sapiens (Human) |
Description: | P27338 |
Residue: | 520 |
Sequence: | MSNKCDVVVVGGGISGMAAAKLLHDSGLNVVVLEARDRVGGRTYTLRNQKVKYVDLGGSY
VGPTQNRILRLAKELGLETYKVNEVERLIHHVKGKSYPFRGPFPPVWNPITYLDHNNFWR
TMDDMGREIPSDAPWKAPLAEEWDNMTMKELLDKLCWTESAKQLATLFVNLCVTAETHEV
SALWFLWYVKQCGGTTRIISTTNGGQERKFVGGSGQVSERIMDLLGDRVKLERPVIYIDQ
TRENVLVETLNHEMYEAKYVISAIPPTLGMKIHFNPPLPMMRNQMITRVPLGSVIKCIVY
YKEPFWRKKDYCGTMIIDGEEAPVAYTLDDTKPEGNYAAIMGFILAHKARKLARLTKEER
LKKLCELYAKVLGSLEALEPVHYEEKNWCEEQYSGGCYTTYFPPGILTQYGRVLRQPVDR
IYFAGTETATHWSGYMEGAVEAGERAAREILHAMGKIPEDEIWQSEPESVDVPAQPITTT
FLERHLPSVPGLLRLIGLTTIFSATALGFLAHKRGLLVRV
|
|
|
BDBM15581 |
---|
n/a |
---|
Name | BDBM15581 |
Synonyms: | CHEMBL8706 | CLG | CLORGILINE | Clorgyline | N-[3-(2,4-dichlorophenoxy)propyl]-N-methyl-prop-2-yn-1-amine | US8633208, Clorgyline | US9603833, Clorgyline | [3-(2,4-dichlorophenoxy)propyl](methyl)prop-2-yn-1-ylamine |
Type | Small organic molecule |
Emp. Form. | C13H15Cl2NO |
Mol. Mass. | 272.17 |
SMILES | CN(CCCOc1ccc(Cl)cc1Cl)CC#C |
Structure |
|